Journal of Biological Chemistry
Volume 276, Issue 38, 21 September 2001, Pages 35847-35853
Journal home page for Journal of Biological Chemistry

MOLECULAR BASIS OF CELL AND DEVELOPMENTAL BIOLOGY
The Notch Intracellular Domain Is Ubiquitinated and Negatively Regulated by the Mammalian Sel-10 Homolog*

https://doi.org/10.1074/jbc.M103992200Get rights and content
Under a Creative Commons license
open access

The Caenorhabditis elegans sel-10 protein is structurally similar to E3 ubiquitin ligases and is a negative regulator of Notch (lin-12) and presenilin signaling. In this report, we characterize the mammalian Sel-10 homolog (mSel-10) and analyze its effects on Notch signaling. We find that mSel-10 localizes to the cell nucleus, and that it physically interacts with the Notch 1 intracellular domain (IC) and reduces Notch 1 IC-mediated activation of the HES 1 promoter. Notch 1 IC is ubiquitinated by mSel-10, and ubiquitination requires the presence of the most carboxyl-terminal region of the Notch IC, including the PEST domain. In the presence of the proteasome inhibitor MG132, the amount of Notch 1 IC and its level of ubiquitination are increased. Interestingly, this accumulation of Notch 1 IC in the presence of MG132 is accompanied by decreased activation of the HES 1 promoter, suggesting that ubiquitinated Notch 1 IC is a less potent transactivator. Finally, we show that mSel-10 itself is ubiquitinated and degraded by the proteasome. In conclusion, these data reveal the importance of ubiquitination and proteasome-mediated degradation for the activity and turnover of Notch ICs, and demonstrate that mSel-10 plays a key role in this process.

Cited by (0)

Published, JBC Papers in Press, July 18, 2001, DOI 10.1074/jbc.M103992200

*

This work was supported by grants from Cancerfonden, EU Project QLRT-1999–30934 (to U. L.), and the Foundation for Strategic Research (to C. Ö.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: deCode Genetics, 110 Reykjavik, Iceland.